Intellectus Partners’s Twist Bioscience TWST Stock Holding History

Intellectus Partners’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-28,058	Closed	-$1.39M	–	271
2022 Q1	$1.39M	Hold	28,058	–	–	0.41%	65
2021 Q4	$2.17M	Hold	28,058	–	–	0.55%	44
2021 Q3	$3M	Hold	28,058	–	–	0.73%	31
2021 Q2	$3.74M	Hold	28,058	–	–	0.84%	23
2021 Q1	$3.48M	Hold	28,058	–	–	0.95%	18
2020 Q4	$3.96M	Sell	28,058 -400	-1%	-$44.4K	1.19%	14
2020 Q3	$2.16M	Sell	28,458 -1,000	-3%	-$62.3K	0.82%	27
2020 Q2	$1.33M	Hold	29,458	–	–	0.52%	48
2020 Q1	$901K	Hold	29,458	–	–	0.43%	66
2019 Q4	$619K	Hold	29,458	–	–	0.25%	132
2019 Q3	$703K	Hold	29,458	–	–	0.31%	99
2019 Q2	$855K	Buy	+29,458	New	+$779K	0.37%	80
2019 Q1	–	Sell	-291,112	Closed	-$4.08M	–	440
2018 Q4	$4.08M	Buy	+291,112	New	+$6.45M	2.8%	7

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Intellectus Partners's TWST Position: Q2 2022 in Review

Intellectus Partners sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 28,058 shares — an estimated $1.39M sold.

Intellectus Partners first reported a position in TWST in Q4 2018 and held it in 13 quarters. The position peaked at $4.08M in Q4 2018. 203 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

Intellectus Partners reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
Intellectus Partners sold 28,058 Twist Bioscience shares in Q2 2022, an estimated $1.39M.
Intellectus Partners first reported a position in Twist Bioscience in Q4 2018 and held it in 13 quarters.
Intellectus Partners's Twist Bioscience position peaked at $4.08M in Q4 2018.
203 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on Intellectus Partners's 13F filing for Q2 2022, filed 12 Aug 2022.